Palisade Bio (PALI) Reiterated at Buy by Stifel on Ph1b Topline Data
Tweet Send to a Friend
Stifel analyst Alex Thompson reiterated a Buy rating and $5.00 price target on Palisade Bio Inc. (NASDAQ: PALI).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
